{"date":"2025-06-30","count":44,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6796-2025-06-30-2031-1oq90ri","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2025-06-30","time":"20:31:05","subject":"更正114年5月背書保證資訊揭露明細表資訊","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2025-06-30 20:31，「更正114年5月背書保證資訊揭露明細表資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2025-06-30-2030-njqsxk","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2025-06-30","time":"20:30:46","subject":"補正公告本公司新增背書保證金額達新臺幣三千萬元以上且達公司最近期財務報表淨值百分之五以上","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2025-06-30 20:30，「補正公告本公司新增背書保證金額達新臺幣三千萬元以上且達公司最近期財務報表淨值百分之五以上」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2025-06-30-2009-11s0sz9","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2025-06-30","time":"20:09:48","subject":"公告本公司代理發言人、會計主管、財務主管及公司治理主管異動","clause":"第8款","fact_date":"2025-06-30","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2025-06-30 20:09，「公告本公司代理發言人、會計主管、財務主管及公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-06-30-1939-1kdb6sh","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-06-30","time":"19:39:14","subject":"公告本公司第六屆薪資報酬委員會委員","clause":"第6款","fact_date":"2025-06-30","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-06-30 19:39，「公告本公司第六屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-06-30-1938-1r2d1uw","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-06-30","time":"19:38:46","subject":"公告本公司第三屆審計委員會委員","clause":"第6款","fact_date":"2025-06-30","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-06-30 19:38，「公告本公司第三屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-06-30-1938-1jx2nfz","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-06-30","time":"19:38:15","subject":"公告本公司股東會通過同意解除新選任董事及其代表人競業禁止之限制案","clause":"第21款","fact_date":"2025-06-30","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-06-30 19:38，「公告本公司股東會通過同意解除新選任董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-06-30-1937-s0kpz3","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-06-30","time":"19:37:43","subject":"公告本公司董事會推選董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-06-30 19:37，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-06-30-1937-1udd9xf","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-06-30","time":"19:37:08","subject":"公告本公司新任法人董事指派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-06-30 19:37，「公告本公司新任法人董事指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-06-30-1936-1tnujv1","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-06-30","time":"19:36:29","subject":"公告本公司114年股東常會改選董事(含獨立董事)當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-06-30 19:36，「公告本公司114年股東常會改選董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-06-30-1935-ds864w","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-06-30","time":"19:35:54","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-06-30 19:35，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2025-06-30-1922-1pbmogz","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-06-30","time":"19:22:45","subject":"公告本公司114年5月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"第44款","fact_date":"2025-06-30","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-06-30 19:22，「公告本公司114年5月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-06-30-1909-1r2z6ji","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-06-30","time":"19:09:00","subject":"代子公司保瑞聯邦股份有限公司公告法人董事改派代表人","clause":"第6款","fact_date":"2025-06-30","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-06-30 19:09，「代子公司保瑞聯邦股份有限公司公告法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-06-30-1908-54swv6","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-06-30","time":"19:08:21","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2025-06-30","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-06-30 19:08，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-06-30-1904-1vu6naf","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-06-30","time":"19:04:30","subject":"董事會決議召開114年第一次股東臨時會公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-06-30 19:04，「董事會決議召開114年第一次股東臨時會公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2025-06-30-1836-p9bs5i","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2025-06-30","time":"18:36:03","subject":"公告本公司重要營運主管異動","clause":"第11款","fact_date":"2025-06-30","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2025-06-30 18:36，「公告本公司重要營運主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-06-30-1828-1gmbyiw","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-06-30","time":"18:28:19","subject":"本公司控股子公司FBD與上海復宏漢霖生物技術股份有限公司簽訂抗癌生物新藥HCB101中國大陸、港澳、東南亞特定國家，及所有MENA地區國家市場獨家授權合約。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-06-30 18:28，「本公司控股子公司FBD與上海復宏漢霖生物技術股份有限公司簽訂抗癌生物新藥HCB101中國大陸、港澳、東南亞特定國家，及所」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-06-30-1751-ds864w","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-06-30","time":"17:51:41","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-06-30","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-06-30 17:51，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-06-30-1750-j2ctdj","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-06-30","time":"17:50:43","subject":"公告本公司第二屆薪資報酬委員會委員及選任召集人","clause":"第6款","fact_date":"2025-06-30","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-06-30 17:50，「公告本公司第二屆薪資報酬委員會委員及選任召集人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-06-30-1749-1rzu4my","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-06-30","time":"17:49:46","subject":"公告本公司第二屆審計委員會委員及選任召集人","clause":"第6款","fact_date":"2025-06-30","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-06-30 17:49，「公告本公司第二屆審計委員會委員及選任召集人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-06-30-1748-1hkjo61","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-06-30","time":"17:48:50","subject":"本公司114年股東常會全面改選董事(含獨立董事)及變動達三分之一","clause":"第6款","fact_date":"2025-06-30","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-06-30 17:48，「本公司114年股東常會全面改選董事(含獨立董事)及變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-06-30-1747-1qb8x0m","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-06-30","time":"17:47:48","subject":"公告本公司114年股東常會通過解除新任董事暨其代表人競業禁止之限制","clause":"第21款","fact_date":"2025-06-30","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-06-30 17:47，「公告本公司114年股東常會通過解除新任董事暨其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-06-30-1746-1n5rhr7","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-06-30","time":"17:46:19","subject":"公告本公司選任董事長","clause":"第6款","fact_date":"2025-06-30","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-06-30 17:46，「公告本公司選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-06-30-1741-1bkm0mx","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-06-30","time":"17:41:03","subject":"公告本公司代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-06-30 17:41，「公告本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-06-30-1734-1cns22","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-06-30","time":"17:34:02","subject":"公告解除新任董事及其法人董事代表人競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-06-30 17:34，「公告解除新任董事及其法人董事代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-06-30-1733-5s1nc2","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-06-30","time":"17:33:39","subject":"公告本公司公司第二屆薪資報酬委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-06-30 17:33，「公告本公司公司第二屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-06-30-1733-9769qc","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-06-30","time":"17:33:11","subject":"公告本公司董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-06-30 17:33，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-06-30-1732-shvl63","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-06-30","time":"17:32:42","subject":"公告本公司公司第二屆審計委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-06-30 17:32，「公告本公司公司第二屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-06-30-1732-1scfpzc","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-06-30","time":"17:32:04","subject":"公告本公司114年股東會全面改選董事(含獨立董事)當選名單暨董事變動達三分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-06-30 17:32，「公告本公司114年股東會全面改選董事(含獨立董事)當選名單暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-06-30-1730-ds864w","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-06-30","time":"17:30:55","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-06-30 17:30，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2025-06-30-1718-1roellr","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-06-30","time":"17:18:53","subject":"公告本公司董事辭任","clause":"第6款","fact_date":"2025-06-30","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-06-30 17:18，「公告本公司董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-06-30-1716-fxkrde","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-06-30","time":"17:16:35","subject":"公告本公司薪資報酬委員會委員辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-06-30 17:16，「公告本公司薪資報酬委員會委員辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-06-30-1716-16y0bl7","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-06-30","time":"17:16:24","subject":"公告本公司審計委員會委員辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-06-30 17:16，「公告本公司審計委員會委員辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-06-30-1715-qrsqda","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-06-30","time":"17:15:52","subject":"公告本公司獨立董事辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-06-30 17:15，「公告本公司獨立董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2025-06-30-1712-p3l3cc","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2025-06-30","time":"17:12:59","subject":"本公司法人董事改派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2025-06-30 17:12，「本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-06-30-1642-l7qirp","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-06-30","time":"16:42:19","subject":"公告本公司會計主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-06-30 16:42，「公告本公司會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2025-06-30-1613-xo2pc7","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-30","time":"16:13:23","subject":"公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"第9款","fact_date":"2025-06-30","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2025-06-30 16:13，「公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2025-06-30-1611-xcqdfw","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-30","time":"16:11:13","subject":"公告本公司董事會決議辦理現金增資發行新股相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2025-06-30 16:11，「公告本公司董事會決議辦理現金增資發行新股相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2025-06-30-1607-qgzrpe","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2025-06-30","time":"16:07:17","subject":"公告本公司發言人、財務主管、會計主管及代理發言人異動","clause":"第11款","fact_date":"2025-06-30","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2025-06-30 16:07，「公告本公司發言人、財務主管、會計主管及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2025-06-30-1546-ucdhp0","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-30","time":"15:46:50","subject":"公告本公司董事會決議授權董事長全權處理剋必達錠獨家授權銷售合約終止事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2025-06-30 15:46，「公告本公司董事會決議授權董事長全權處理剋必達錠獨家授權銷售合約終止事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-06-30-0644-63lx8n","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-06-30","time":"06:44:54","subject":"公告本公司董事會通過美國子公司簽署生物相似藥TX01（Neupogen Biosimilar）授權經銷合約","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-06-30 06:44，「公告本公司董事會通過美國子公司簽署生物相似藥TX01（Neupogen Biosimilar）授權經銷合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2025-06-30-0123-l20llz","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2025-06-30","time":"01:23:31","subject":"公告本公司第一屆審計委員會成員","clause":"第9款","fact_date":"2025-06-27","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2025-06-30 01:23，「公告本公司第一屆審計委員會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2025-06-30-0122-etokuk","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2025-06-30","time":"01:22:13","subject":"公告本公司114年股東常會通過解除董事及新任獨立董事競業禁止之限制","clause":"第9款","fact_date":"2025-06-27","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2025-06-30 01:22，「公告本公司114年股東常會通過解除董事及新任獨立董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2025-06-30-0115-13rm3y2","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2025-06-30","time":"01:15:01","subject":"公告本公司民國114年股東常會獨立董事當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2025-06-30 01:15，「公告本公司民國114年股東常會獨立董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2025-06-30-0113-ds864w","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2025-06-30","time":"01:13:14","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2025-06-30 01:13，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}